Published March 25, 2021By Lauren Manning
- “…CBD products do not cause liver damage when taken orally, according to a new study from Validcare. The seven-month analysis evaluated the impact of CBD on liver health through clinical trials involving 839 participants.
- The study was conducted at the FDA’s request to inform the federal agency’s developing regulatory approach to CBD products. Twelve CBD industry companies helped fund the study, provided certificates of authenticity and recruited survey participants.
A summer 2019 study involving mice suggested that there may be a link between CBD and liver damage. Critics pushed for a human study, like Validcare’s, saying there are differences between how CBD functions in mice versus humans, and most people would not ingest the level of CBD provided to rodents in the study.
The results of the study are likely good news for players in the CBD industry who may have been fearing heavy restrictions, should the results have raised red flags…”